Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a gentle brain zap restore movement and ease pelvic pain?

NCT ID NCT06891690

Symptom relief Sponsor: Poznan University of Physical Education Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 24, 2026 · Last updated Sep 25, 2026 · Updated 1 time

Summary

Researchers are testing transcranial direct current stimulation (tDCS), a non-invasive technique that applies a weak electrical current to the scalp, in people with neurological conditions like stroke and spinal cord disorders, and in women with gynecological conditions such as endometriosis and painful periods. The study aims to see if tDCS can improve upper and lower limb function and reduce pelvic pain. About 300 participants will receive one to ten sessions of tDCS, and researchers will measure changes in movement, pain, and quality of life using standard questionnaires and physical tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcranial direct current stimulation (tDCS), a mild electrical current applied to the scalp
What this could lead to
If it works, tDCS could offer a drug-free way to help people regain limb function after stroke or spinal cord problems and to reduce pelvic pain from conditions like endometriosis.
What could go wrong
This is an early study with no control group, so any improvements could be due to chance or placebo. tDCS can cause mild scalp tingling or headache, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Neurological patients Inclusion Criteria: * impairment of upper and lower limb function. Exclusion Criteria: * no written consent to participate in the study. Gynaecological patients Inclusion Criteria: * women with selected gynaecological conditions (endometriosis, painful menstruation, dyspareunia, polycystic ovary syndrome) with no treatment other than tDCS stimulation. Exclusion Criteria: * no written consent to participate in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dyspareunia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dysmenorrhea endometriosis Pain polycystic ovary syndrome psychologic dyspareunia radiculopathy spinal cord disorder stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dyspareunia Endometriosis Nerve root disorder Painful menstruation Polycystic ovary Spinal cord diseases Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • 1Department of Physiotherapy, Poznan University of Physical Education, Faculty of Sport Sciences in Gorzow Wlkp., 61-871 Poznan

    RECRUITING

    Poznan, 61-871, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.